Payout ahead of earnings. A 2.5% yield and a raise streak running since 2010 are real, but the dividend is not covered by trailing earnings — the $2.52 annualized rate runs past the $1.74 of trailing GAAP EPS, and dividends paid exceeded net earnings in the first nine months of fiscal 2026. Cash flow covered the check in that period ($3.6 billion of operating cash flow against $2.12 billion paid), so the question the turnaround has to answer is earnings, not cash today: until EPS rises to the payout, each token raise adds to a rate earnings have not yet caught up with.
Key risk: The turnaround itself — “Back to Starbucks” costs and restructuring charges are what held GAAP EPS to $1.74 trailing while the dividend ran at $2.52 annualized. If comparable-sales and margin gains stall before earnings reach the payout, the dividend is funded from cash flow and the balance sheet, and the raise streak is the first thing at risk.
Changes if: Trailing GAAP EPS rises above the $2.52 annualized dividend — coverage restored — or it does not: another year with dividends paid above net earnings, a freeze, or a cut would change this verdict. At a 144.8% trailing GAAP payout, earnings have to do the moving.
- ✗Payout-coverage check: Not covered by earnings — the $2.52 annualized rate is 144.8% of trailing GAAP diluted EPS of $1.74 (through Q3 fiscal 2026), and cash dividends paid of $2.12 billion in the first nine months of fiscal 2026 exceeded net earnings attributable to Starbucks of $1.85 billion. Even against the raised fiscal 2026 non-GAAP EPS guide of $2.55–$2.65, the rate takes about 97% of the midpoint.
- ✓Yield check: 2.5% indicated ($0.63 × 4 ÷ $100.80, the Oct. 23, 2026 close) is real cash yield from a regular quarterly dividend — no special dividend inflating it. It passes on size; the risk sits in coverage, not in how the yield is made.
- !Dividend growth check: 16th consecutive annual increase since the dividend began in 2010, but the raises have shrunk to token size: $0.57 to $0.61 in 2024 (+7.0%), then $0.61 to $0.62 in 2025 (+1.6%) and $0.62 to $0.63 on Oct. 7, 2026 (+1.6%). Streak intact, growth minimal.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.